Chapter 13: Mucocutaneous Fungal Infections

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Usually we picture the human body as a perfectly sealed sterile fortress.

Oh yeah?

But the truth is, your skin is a bustling ecosystem.

Yeah, a microscopic jungle teeming with bacteria and fungi, all basically competing for real estate.

Exactly.

And most of the time, there is this quiet, invisible harmony.

But when that balance collapses, things get really ugly.

They absolutely do.

So to the advanced practice nursing student listening right now, welcome to today's Deep Dive.

Today, we are looking at what happens when that microscopic flora turns into a raging,

opportunistic infection.

And more importantly, how you, as a future clinician, can safely stop it.

Right.

Because our mission today is to provide a customized one -on -one tutoring session covering Chapter 13, which is mucocutaneous fungal infections.

From primary care, the art and science of advanced practice nursing.

Yes.

And we are going to move through the exact order of the chapter.

We're letting the foundational pathophysiology support our assessment findings.

Which then drives your clinical reasoning.

Exactly.

Which gets us to our diagnosis.

And finally, safe, patient -centered management.

Because the jump from a harmless resident fungus to a symptomatic infection is, I mean, it's a masterclass in pathophysiology.

Mastering these infections isn't just about memorizing dermatology.

Right.

It requires a systemic understanding of cellular immunity, pharmacology, and patient safety.

Okay.

Let's unpack this.

Start with Candida.

Specifically, Candida albicans.

The most ubiquitous fungal pathogen we see.

Yeah.

I mean, up to 20 % of completely asymptomatic women test positive for vaginal Candida.

Right.

It is just sitting there.

In the oropharynx, the GI tract, the vaginal tract, just not causing any trouble at all.

And that quiet state is maintained by two primary forces.

First are commensal bacterial flora, and second are intact cellular immunity.

Which is mediated primarily by cytotoxic two cells, right?

They got it.

They constantly keep the yeast in check.

Okay.

But if a patient takes a broad spectrum antibiotic.

But acts like a microscopic forest fire.

Exactly.

It wipes out the normal bacterial flora, completely removing the natural competition for space and nutrients.

I always picture normal flora in those cytotoxic T cells, like a garden's natural weed control.

Oh, that's a great analogy.

Yeah.

Like, you have this beautiful, thick lawn of good bacteria, but when you spray the antibiotic pesticide, you wipe out the good grass.

And the Candida weeds suddenly have all the sunlight and soil they need to completely take over the yard.

Right.

But the host's immune status plays an equally massive role, doesn't it?

Oh, absolutely.

Altered cellular immunity gives Candida the perfect opening to overgrow.

So we see this frequently in patients with AIDS,

diabetes, malatus.

Those undergoing corticosteroid treatment, yeah.

Or even just the naturally immature immune systems of infants.

But wait, if this yeast is already living inside our bodies naturally, why does the immune system suddenly freak out?

Like why the intense itching and bright red erythema?

Yeah.

Why the massive reaction when the Candida overgrows?

Well, the intense erythema and pruritus happen because the Candida organisms aren't just multiplying in empty space.

They're invading, right?

Yes.

They are actively invading the superficial layer of the epithelium.

Wow.

When they invade human tissue, they trigger a massive, aggressive inflammatory response from the host.

So you're not just seeing the yeast on the skin?

No.

You are seeing the active battlefield where your immune system is suddenly fighting off a tissue invasion.

That makes so much sense.

But what's really alarming epidemiologically right now is the massive rise in non -albicans species.

Yes, like Candida glabrata and Candida crusae.

As a prescribing clinician, this shift totally alters your game plan, doesn't it?

It really does.

Widespread and sometimes indiscriminate use of Azole antifungals has pressured these fungi to adapt.

They're fighting back.

Right.

Candida crusae and Candida glabrata have actually developed resistance to our common go -to antifungal flucainazole.

So you have to be really careful.

And location really dictates how this battlefield presents on the patient, right?

It really does.

Take oral candidiasis or thrush.

The patient usually complains of a severe sore throat and dysphagia.

Especially if they try to eat acidic foods like orange juice.

Right.

And objectively, you see these white, creamy patches in the mouth.

But the key diagnostic clue happens when you scrape those patches with a tongue blade.

Yeah, they come off, but they leave behind a tender, epheminous bleeding patch.

Exactly.

Now, if the yeast overgrows in the vaginal tract, the presentation completely shifts.

That's vulvovaginitis.

Yes.

The patient typically reports burning, itching, and a thick white discharge,

classically described as having a cottage cheese texture.

Ugh, classic textbook description.

And they might also report burning during urination or intercourse, right?

Right, due to the inflamed tissues.

And we can't forget ballonitis, which affects the gland's penis.

This usually presents as a reddish rash and itching.

And it is incredibly common in uncircumcised men who have diabetes.

Yeah, because that foreskin traps the necessary heat and moisture for the yeast to thrive.

While the underlying diabetes basically blunts the cellular, unknown response.

Exactly.

We also frequently see endertygenous candidiasis.

That happens in the skin folds, right?

Like the inframammary area under the breasts, the groin, the axillae.

And the web spaces of fingers and toes.

And there is a massive neon flashing cardinal sign for cutaneous candidiasis here.

The satellite lesions.

Yes.

You are looking for a bright red, weepy patch of macerated skin, but the ultimate giveaway is on the borders.

Those tiny separate red macules spreading out beyond the main rash.

Right.

What exactly are those?

Those satellite lesions are actually small, pioneer colonies of Candida that have spread out.

Oh, wow.

So they're like advanced scouts.

Yeah.

And they will eventually merge with the main lesion.

If you see bright red folds with satellite lesions, Candida should immediately pop your differential diagnosis.

But as an advanced practice nurse, you can't always rely on the naked eye.

Definitely not.

We need objective data to drive clinical reasoning.

Right.

So we rely on two primary microscopic techniques, the saline wet mount and the potassium hydroxide or KOH test.

The saline wet mount is incredibly fast and usually the go -to for vaginal candidiasis.

But you have to pair that wet mount with a pH test, don't you?

You do.

Oh.

To firmly distinguish Candida from bacterial vaginosis or BV.

Because with Candida, the vaginal pH will be normal, meaning acidic, at 4 .5 or less.

And if you do a WIF test, it will be negative.

Right.

BV, conversely, gives you a high pH and a positive WIF test.

Exactly.

Now for skin scrapings, like a rash under the breast,

a wet mount won't work.

Right.

You have to use the KOH prep.

Yeah.

I think of KOH as this microscopic camouflage remover.

You scrape the skin, put it on a slide, add the potassium hydroxide, and gently heat it.

And the alkaline KOH literally dissolves the thick human keratin cells that are hiding the fungus.

Leaving only the tough fungal walls behind so you can actually see them.

Right.

But practically speaking, when you're looking into that microscope lens, how do you know you're not just looking at a random piece of lint or a stray fiber from the patient's shirt?

What's fascinating here is how distinct true fungi are if you know what to look for.

Okay.

Tell me what to look for.

Well, a piece of hair or a cotton thread will appear as a solid black opaque line.

Got it.

Solid and black.

But true fungal hyphae are completely translucent and colorless.

Oh, okay.

They have thin walls with complete or partial septa dividing each segment.

It makes them look exactly like tiny bamboo stems.

Bamboo stems.

That is a visual that really sticks.

And you'll also see stores, which are small oval shapes sitting either alone or in clusters.

But there is a massive clinical reasoning pearl we have to highlight here for the listener.

The asymptomatic culture.

Yes.

Because Candida is part of the normal human flora, a positive culture from the mouth or vagina is completely meaningless.

Unless it is accompanied by actual clinical signs and symptoms.

Exactly.

Treat the patient, not the test.

If the patient has no itching, no erythema, and no discharge, but their swab grows Candida, you do not treat it.

But you are just identifying their normal flora.

Right.

But once you've made a confirmed diagnosis based on symptoms and objective data, how do we fix it safely?

Well, there's a foundational prescribing rule regarding vehicle selection, meaning what physical form the medication takes.

Right.

So use powders for moist, macerated, weeping lesions like you'd see in the groin or under the breast.

And use creams for dry lesions.

Because powders help absorb the excess moisture that the yeast thrives on, while creams provide necessary hydration to dry, cracked skin.

But never, ever use alcohol -based solutions or sprays on inflamed or macerated skin.

Oh, definitely not.

It will cause severe agonizing burning for your patient.

Do not do it.

Okay.

So for pharmacologic interventions, first -line treatment for vulva vaginitis is a topical or oral azole.

You can prescribe a 7 to 14 -day course of the topical azole cream.

Or a single oral 150 -milligram dose of fluconazole, right?

Yes.

But scope of practice and safety alert here.

If the patient is pregnant, the guidelines change entirely.

Oh, right.

Because of the oral medication risks.

Pregnant patients should only be treated with topical azole therapy for seven days.

Wait, no single oral dose of fluconazole?

While that single oral dose hasn't been definitively proven unsafe, the standard of care dictates topical only.

Got it.

And if it's a recalcitrant case, that won't clear up.

Your role is to refer that patient to their obstetrician.

So what does this all mean for the patient going home?

It means your prescription pad is only half the battle.

Right.

The other half is health promotion and non -pharmacologic management.

You have to teach the patient to alter their microenvironment so the yeast can't survive.

We know Candida loves heat and moisture.

So patients need to keep endotrigenous areas dry.

They can use clean, dry, white tissues between deep folds of skin to absorb sweat.

I read they can even use a hairdryer to dry those skin folds after a shower.

They can, but you must explicitly stress to them to use the low heat setting.

Because if you don't… Skipping that detail leads to patients coming back with severe burn injuries on highly sensitive, already inflamed skin.

Ouch.

Also, tell them to completely avoid any baby powders that contain cornstarch.

Yes.

Cornstarch is a carbohydrate.

And Candida is a yeast.

You are literally feeding the infection.

It is a very common mistake patients make with over -the -counter remedies, assuming all powders are created equal.

So we've seen how opportunistic yeasts like Candida exploit a weakened defense.

But what about fungi that don't wait for an invitation?

You mean the ones that actively hunt and consume our tissue?

Yeah.

The aggressive ones.

Those are the dermatophytoses, also known as tinea infections.

Unlike Candida, which is an opportunistic yeast that just overgrows.

Dermatophytes are true parasitic fungi.

They belong to three main species – Trichophyton, Epidermophyton, and Microsporum.

What makes them unique is their diet, right?

Yes.

They actively metabolize and digest keratin.

Which is the structural protein that makes up the protective top layer of our skin, our hair, and our nails.

They are literally keratin eaters.

And because they survive on our outer surfaces, they are highly contagious.

You catch them through direct contact with an infected purser, an animal like a dog or cat, or even fomites like combs or hats.

Right.

Trachophyton tonturans causes 90 % of all tinea capitis, which is scalp ringworm, in the U .S.

And it produces so many infectious spores that it regularly causes epidemics in schools.

Looking at the clinical presentations by anatomical location, tinea corporis or body ringworm,

it's a classic presentation.

Yeah, the patient has an erythematous, round, elevated lesion that starts to clear in the center.

Giving it that perfect iconic ring shape.

Then there is tinea crurus, better known as jock itch.

The patient comes in with a red, itchy rash in the groin.

How do you know if it's candida, inner trigo, or tinea crurus?

Well, tinea crurus spreads down the inner thigh, but it spares the scrotum.

Wait, it spares it, because candida...

Candida will gleefully infect the scrotum and the penis.

That simple anatomical boundary is a huge diagnostic differentiator.

It really is.

Next is tinea pedis, or athlete's foot.

This usually presents as macerated, white, peeling skin in the toe webs, right?

Or as a moccasin -type scaling that thickens the skin on the soles of both feet.

And this specific moccasin presentation is usually caused by trichophyton rubrum.

But this triggers a wild immune response that we have to talk about.

If we connect this to the bigger picture of immunology,

we see something called a dermatophytid, or id -ereption.

This is a systemic hypersensitivity reaction to the fungus on the foot, right?

Exactly.

The patient develops these intense, burning, fluid -filled vesicles on the sides of their fingers or the palms of their hands.

And if you culture those blisters on the hands...

Nothing.

They are totally sterile.

There is zero fungus in them.

Right.

It's just the immune system overreacting to the fungus way down on the feet.

The body is so inflamed by the toe infection that it essentially breaks out in sympathetic hives on the hands.

Yeah.

It's amazing.

But because tinea actively invades hair follicles and deep nail beds,

topical creams often can't penetrate deep enough to reach the root of the infection.

That means escalating to systemic oral therapies.

And as an advanced practice nurse, the moment you move to systemic antifungals, your safety and monitoring priorities must skyrocket.

I've seen clinicians just pull out a woods light in the clinic, wave it over the scalp, and if the skin doesn't glow, they confidently send the patient home.

Oh no.

But that's actually a massive diagnostic trap, isn't it?

It is a dangerous oversimplification.

A woods light will cause certain minor species, like microsporum canis, to fluoresce a brilliant bright green.

Okay, but what about trachophyton tonsurans?

Well, trachophyton tonsurans, which we just established, causes 90 % of tinea capitis,

does not fluoresce under a woods light.

Wait, the one that causes 90 % of cases doesn't glow.

Exactly.

If you rely solely on a negative woods light, you will confidently misdiagnose 90 % of your scalp ringworm cases.

Wow.

You have to do a fungal culture.

In fact, a fungal culture is mandatory, not optional, mandatory before you start a patient on systemic oral treatment for tinea capitis or tinea ungeum.

The reason it is mandatory is the side -effect profile of these systemic drugs.

You cannot subject a patient to months of potentially liver -toxic medications without proof positive of the organism you're fighting.

Absolutely.

So let's look at that pharmacologic management.

For topicals, you're using adults for two to four weeks.

And you tell the patient to keep applying it for a full week after the skin looks totally clear to kill any microscopic stragglers.

But for systemic drugs like grizafulvin or turbinifine,

the provider responsibilities are heavy.

What do we need to do before starting them?

Before starting systemic therapy, the clinician must order baseline liver function tests, or LFTs, and a complete blood count, or CBC.

And then you repeat those labs at four weeks, right?

Yes.

These drugs carry serious risks of hepatotoxicity, as well as blood disgraceas like leukopenia and granulocytopenia.

You have to monitor the patient for signs of liver distress, like jaundice, profound malaise, and dark urine.

Very closely.

Here's where it gets really interesting, and a little scary, honestly.

Let's look at grizafulvin.

Grizafulvin actively decreases the effectiveness of oral contraceptives.

So if you don't warn your female patient to use backup barrier methods, she could end up with an unintended pregnancy.

Furthermore, it is teratogenic to male sperm.

Yes.

Male patients must avoid fathering a child during treatment.

And they must wait a full six months after stopping grizafulvin before trying to conceive.

Those are major scope of practice and informed consent discussions you must have before handing over that prescription.

It is your responsibility to ensure the patient fully understands the stakes.

It really is.

Which brings us to onychomycosis, also known as tinea unguium, nail fungus.

Oh boy.

This feels like the absolute final boss of dermatophyte infections.

Onychomycosis is incredibly stubborn.

The pathogen, usually trichophytin rubrum, gets deep under the nail plate.

And the thick keratin of the nail acts as a physical shield against topical creams, preventing the medication from reaching the fungus.

Furthermore, the typically poor circulation in the toes, especially in older adults or diabetics, means systemic oral drugs have a hard time reaching the site in high enough concentrations to be effective.

Clinically, it presents as thick, cloudy, yellow, or discolored nails that often detach from the nail bed.

Right.

It's usually entirely asymptomatic.

No pain.

Just a cosmetic concern that deeply bothers the patient.

So for evidence -based management, systemic therapy is the most effective route.

Yes.

The first line choice is oral turbinifine.

It has a superior cure rate and far fewer drug interactions compared to alternatives like eitrichonazole.

But the timeline is brutal.

It is.

You treat the patient for 12 weeks with the oral medication, but they won't see the final result until they nail fully regrows.

Which takes 6 to 9 months for fingernails and a massive 12 to 18 months for toenails?

You have to manage their expectations.

Or they will quit the drug at month 3, assuming it failed because their nail still looks terrible.

Right.

Because oral drugs are so taxing and take so long, a lot of patients ask for complementary or home remedies.

And there is anecdotal and small study success with treating nail fungus using tea tree oil, white vinegar.

And get this, Vicks Vaporub, the mentholated petrolatum.

Yeah.

Small studies have shown that the menthol and camphor and those specific rubs can actually inhibit fungal growth.

That's wild.

This raises an important question for you as the future clinician.

You are faced with an infection that is largely cosmetic and asymptomatic.

Right.

Do you put the patient on an aggressive, systemic oral medication that taxes their liver, risks blood disgraceas, and requires monthly blood draws?

Or do you lean toward these benign topical approaches or even suggest no treatment at It's the ultimate test of shared decision making.

You have to lay out the risks of liver toxicity versus the benefit of a clear toenail and let the patient decide what matters most to them.

Exactly.

It's not just about knowing the drug mechanisms.

It's about treating the whole patient and understanding their priorities.

As we wrap up this deep dive, I want to leave you with something to ponder.

We've spent this whole session talking about how to assess, diagnose, and eradicate these fungi.

But remember, fungi are ubiquitous.

They live in our soil, in our showers, and permanently on our skin.

Rather than viewing them purely as invading enemies, what if we started viewing fungal overgrowth as a vital check engine light for our body's immune system?

That's a profound way to look at it.

If a patient keeps coming in with recurrent thrush or unrelenting tinea pedis, maybe the fungus isn't the real problem.

Maybe it's the warning siren alerting you to an undiagnosed case of diabetes, a severe microbiome imbalance, or an underlying immune suppression.

Long before any other systemic symptoms appear.

The fungus is just the messenger.

It's your job to decipher the message.

Keep studying.

Trust your foundational science to drive your clinical reasoning, and always look at the bigger picture.

On behalf of the deep dive and the last minute lecture team, thanks for listening, and we'll see you next time.